MedTrace Logo

Monitoring Changes in Blood Pressure

NCT02641327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-12-01

No results posted yet for this study

Summary

The study objective is to assess the accuracy of Earlysense contactless monitoring to detect changes in blood pressure vs. Gold reference method / devices including ambulatory blood pressure monitoring device (ABPM) or invasive blood pressure monitoring for patients who have arterial line as part of their standard clinical care.

Conditions

  • Blood Pressure

Interventions

DEVICE

EarlySense (Passive monitoring)

Passive contact-free monitoring

Sponsors & Collaborators

  • EarlySense Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02641327 on ClinicalTrials.gov